Stocks & Investing
Stocks and Investing
Stocks and Investing
Sun, November 24, 2024
[ 02:55 PM ] - Thomas Matters
Wed, November 13, 2024
[ 09:28 AM ] - George Steinberg
[ 09:24 AM ] - George Steinberg
Tue, November 12, 2024
[ 07:01 PM ] - George Steinberg
[ 06:39 PM ] - George Steinberg
Tue, October 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024
Robert Driscoll of Wedbush, Reiterated "Black Diamond Therapeutics, Inc." (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024.
Robert has made no other calls on BDTX in the last 4 months.
There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Tuesday, September 24th, 2024
- Joseph Catanzaro of "Piper Sandler" Maintained at Buy with Increased Target to $15 on, Monday, September 23rd, 2024
- Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024
